Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 13.53
Day High 14.51
Open:13.90
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed brand. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

COVID-19 Killed North Dakota’s Marijuana Legalization Dreams
- Market Realist - Mon Apr 6, 10:05AM CDT
Market Realist - CMTX
Mon Apr 6, 10:05AM CDT
Right now, marijuana legalization in 2020 doesn't seem possible for many states due to the COVID-19 pandemic. Since the pandemic hit, states have taken numerous measures to impose social distancing. Currently, social distancing is the only effective way to contain the spread of the virus. Canceling large public events and gatherings has put a halt on signature gathering for legalization campaigns. Recently, Idaho suspended its marijuana legalization campaign. The state wasn't able to collect enough signatures. North Dakota might be the next state to cancel its marijuana legalization initiative.
Canopy Growth’s Vaporizer Device Gets Health Canada Approval
- Market Realist - Mon Apr 6, 9:33AM CDT
Market Realist - CMTX
Mon Apr 6, 9:33AM CDT
On April 3, Canopy Growth (NYSE:CGC)(TSE:WEED) for Volcano Medic 2--its vaporizing device. Storz & Bickel, a subsidiary of Canopy Growth, developed the product. Canopy Growth acquired the German vaporizer design and manufacturer in December 2018 for approximately 145 million euros. The medical device license allows device distribution to patients, clinics, and medical institutions in Canada. Also, the license allows the distribution through Spectrum Therapeutics--Canopy Growth's medical cannabis division. Earlier, Europe and Australia approved the device for medical use.
Thinking about buying stock in Canopy Growth Corp, Co-Diagnostics, LYFT, Penn National Gaming, or Simply Good Foods?
- PR Newswire - Mon Apr 6, 8:31AM CDT
PR Newswire - CMTX
Mon Apr 6, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CGC, CODX, LYFT, PENN, and SMPL.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 9.00 +59.33% increase
on 03/18/20
Period Open:15.28
Price movement based on the high, low and last over the given period.
16.34 -12.24% decrease
on 03/26/20
-0.94 (-6.15%) decrease
since 03/06/20
3-Month 9.00 +59.33% increase
on 03/18/20
Period Open:20.08
Price movement based on the high, low and last over the given period.
25.97 -44.78% decrease
on 01/15/20
-5.74 (-28.59%) decrease
since 01/06/20
52-Week 9.00 +59.33% increase
on 03/18/20
Period Open:43.24
Price movement based on the high, low and last over the given period.
52.74 -72.81% decrease
on 04/30/19
-28.90 (-66.84%) decrease
since 04/05/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies